There are three GLP-1 FDA decisions expected in early-mid 2026 Eli Lillys Mounjaro with a new indication to reduce the risk of major adverse cardiovascular events (MACE) in patients with T2DM Eli Lillys oral once-daily orforglipron for weight loss Novo Nordisks higher dose (7.2 mg) injectable once-weekly Wegovy for weight loss Given the considerable continued growth expected in the GLP-1 pipeline, Prime Therapeutics talented team of clinical experts actively monitors this emerging landscape
The timing can vary based on age, hormones, and how much weight youve lost
Promotes digestive health and gutbrain axis support
It was found that the metabolic formation of the corresponding phenol glucuronates contributed to this prolonged action
A must-listen episode if you are ready to take the next step in your health journey with everyday, uncomplicated wellness tools, including the best ways to use food as medicine
The appropriate level of care depends on symptom severity, but serious or rapidly worsening symptoms should not be managed by simply waiting for them to pass